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Meeting Schedule -Day 1, 15.01.2017 (Sunday) 
 
Presentation Time Speaker Topic 
Session 1 9.00 – 11.00 am Antimicrobial Resistance 
Lead talk 1 9.00 – 9.30 am 
Prashant Garg/ 
Nagaveni Shivshetty 
Ex-vivo cornea infection model and its utilization 
in evaluating detection devices 
Lead talk 2 9.30 – 10.00 am Virander Singh Chauhan 
Design of conformationally restricted Short 
peptides; Antimicrobial and self assembling 
properties 
Lead talk 3 10:00 – 10.30 am Harpal Singh 
Early detection of pathogenic bacteria and 
strategies to overcome drug resistance using 
MCF7 cell line as a model 
Lead talk 4 10.30 – 11.00 am Hemant Gautam Antibiotic resistance  and future strategies 
11.00 – 11.30 am Tea/ Coffee Break 
Session 2 11.30 – 1.00 pm Biofilm 
Lead talk 5 11.30 – 12.00am S Shivaji 
Ocular Escherichia coli: biofilm formation, 
antimicrobial resistance and gene expression 
Lead talk 6 12.00 – 12.30pm Joey Shepherd Novel methods to treat (and grow!) biofilm 
Lead talk 7 12.30 – 1.00pm 
Dipankar Ghosh/ 
Pallavi Lahiri 
Polymicrobial biofilms and antibiotic resistance: 
the case of Pseudomonas aeruginosa and 
Stenotrophomonas maltophilia. 
1.00 – 2.00 pm Lunch 
Session 3 2.00 – 4.00 pm Non-antibiotic approaches 
Lead talk 8 2.00– 2.30 pm Sheila MacNeil Non-antibiotic approaches to tackling infection 
Lead talk 9 2.30 – 3.00 pm Subhadeep Chatterjee 
Role of iron metabolism in bacterial virulence 
and antimicrobial resistance 
Lead talk 10 3.00–3.30 pm Sanhita Roy 
Role of antimicrobial peptides in bacterial 
keratitis 
Lead talk 11 3.30 – 4.00 pm Maria Katsikogianni 
Manufacturing and testing the efficacy of non-
fouling/antimicrobial materials 
4.00 - 4.30 – pm Tea/ Coffee Break 
Session 4 4.30–6.00 pm Miscellaneous 
Lead talk 12 4.30 – 5.00 pm Sudip Ghosh 
Activation and inactivation of metronidazole in 
Entamoeba and Trichomonas 
Lead talk 13 5.00 – 5.30 pm Mohitosh Mandal 
Targeting chemo-resistant subpopulations in 
breast cancer: An emerging paradigm 
Lead talk 14 5.30 – 6.00 pm Soumyava Basu Intraocular T-cell response in ocular TB 
7.00 pm onward Reception Dinner 
                      Meeting Schedule -Day 2, 16.01.2017 (Monday) 
 
Presentation  Time Speaker Topic 
Session 5 8.00 – 10.00 am Non-antibiotic approaches 
Lead talk 1 8:00 – 8.30 am William Martin 
Hyperbranched polymers for the disruption of 
quorum sensing 
Lead talk 2 8.30 – 9.00 am Nagaraju Konda Melimine-coated antimicrobial contact lenses 
Lead talk 3 9.00 – 9.30 am Sovan Lal Banerjee 
A new class of smart polymeric material to fight 
against microbial attack 
Lead talk 4 9.30 – 10.00 am Anindya Sundar Ghosh Non-essential PBPs and beta-lactam resistance 
10.00 – 10.30 am  Tea/ Coffee Break 
Session 6 10.30 – 1.00 pm Drug Delivery Systems 
Lead talk 5 10.30 – 11.00 am Stephen Rimmer Towards bacteria targeting particles 
Lead talk 6 11.00 – 11.30pm Radha Rangarajan Novel Antibacterials: The Vitas experience 
Lead talk 7 11.30 – 12.00pm V V Vamsi Krishna 
Breaching the membrane barriers for effective 
drug delivery 
Lead talk 8 12.00– 12.30pm Nikhil Singha 
New class of polymeric nano-hybrid material 
based on POSS and its biomedical applications 
Lead talk 9 12.30 – 1.00pm Pradip Paik 
“NO” delivery through crossed-linked polymer 
capsules 
1.00 – 2.00 pm Lunch 
2.00 – 4 .00 pm Discussion 
4.00 - 4.30 –pm Tea/ Coffee Break 
4.30 – 6.00 pm Tour of LV Prasad Eye Institute, Hyderabad 
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12.00 – 1.00 pm Lunch 
 
 
List of participants: 
1. Dr. Prashant Garg 
 Senior consultant 
 TejKohli Cornea Institute 
 L V Prasad Eye Institute 
 L.V. Prasad Marg, Banjara Hills 
 Hyderabad-500034, India 
 Tel: + 91 40 30612504 
 Fax: +91 40 30612535 
 Email: prashant@lvpei.org 
 
2. Dr. V. Vamsi Krishna Venuganti 
 Assistant Professor  
 Department of Pharmacy 
 BITS Pilani, Hyderabad Campus 
 Shameerpet, Hyderabad 500078 
 Tel: +04066303581 
Email: vamsi@hyderabad.bits-pilani.ac.in 
 
3. Dr. Balasubramanian 
 
Prof. Brien Holden Eye Research Center 
L V Prasad Eye Institute 
L V Prasad Marg, Banjara Hills  
Hyderabad-500034, India 
Tel: + 91 40 30612504 
Fax: +91 40 30612535  
Email: dbala@lvpei.org 
 
4. Dr. Virander Singh Chauhan 
 
J. C. Bose Fellow (DST) 
Distinguished Biotechnology Research Professor (DBT) 
International Centre for Genetic Engineering and Biotechnology, New Delhi 
Tel:+91 9811292058 
Email: viranderschauhan@gmail.com 
 
5. Dr. S Shivaji 
 Director; Prof. Brian Holden Eye Research Center 
 L V Prasad Eye Institute 
 KallamAnji Reddy Campus 
 L.V. Prasad Marg, Banjara Hills 
 Hyderabad-500034, India 
 Tel: + 91 40 30612504 
 Fax: +91 40 30612535 
 Email: shivas@lvpei.org 
 
6. Dr. Sanhita Roy 
 Prof. Brien Holden Eye Research Center 
 L V Prasad Eye Institute 
 L V Prasad Marg, Banjara Hills  
 Hyderabad-500034 India 
 Tel: + 91 40 30612504 
 Fax: +91 40 30612535 
 Email: sanhita@lvpei.org 
 
7. Dr. Stephen Rimmer 
 Head of School 
 School of Chemistry and Forensic Sciences 
 Richmond Building 
 University of Bradford 
 Bradford, BD7 1DP 
UK 
Tel: +44 (0) 114 22 29565 
Email: s.rimmer63@gmail.com; s.rimmer@bradford.ac.uk 
 
 
 
 
 
 
 
 
 
 
 
8. Dr. Sheila MacNeil 
 
Professor 
Dept. of Materials Science & Engineering 
Kroto Research Institute 
University of Sheffield 
North Campus, Broad Lane 
Sheffield 
Tel: 0114 222 5995 
Email: s.macneil@sheffield.ac.uk 
 
9. Dr. Maria Katsikogianni 
  
Lecturer 
School of Chemistry 
Faculty of Life Sciences 
University of Bradford 
Tel: +44 (0) 1274236185 
Email: m.katsikogianni@bradford.ac.uk 
 
10. Dr. Joey Shepherd 
 
Lecturer in Oral Microbiology 
Academic Unit of Oral and Maxillofacial Pathology 
School of Clinical Dentistry, room E27 
University of Sheffield 
19 Claremont Crescent 
Sheffield S10 2TA 
Tel: +44 (0)114 2717969 
Email: j.shepherd@sheffield.ac.uk 
 
 
 
 
 
 
 
 
11. Dr. William Martin 
 Lecturer in Chemistry 
 Department of Chemistry and Forensic Sciences 
 J4 Richmond building,  
 University of Bradford 
 Bradford, BD7 1DP 
 UK 
 Tel: +44 (0) 1274 233362  
 Email: w.martin@bradford. ac.uk 
 
12. Dr. Pradip Paik 
 
Assistant Professor 
School of Engineering Sciences and Technology 
University of Hyderabad 
Central University 
Hyderabad – 500046 
Email: ppse@uohyd.ernet.in; pradip.paik@gmail.com 
 
13. Dr. Nikhil Kumar Singha 
  
Professor 
Rubber Technology Centre 
B-218 
Indian Institute of Technology,  
Kharagpur - 721302 
Email: nks@rtc.iitkgp.ernet.in 
 
14. Dr. Dipankar Ghosh 
 
Assistant Professor 
Special Center for Molecular Medicine & 
Center for Advanced Research (ICMR-CAR) 
Jawaharlal Nehru University 
New Delhi – 110067 
E-mail: ghoshd@jnu.ac.in 
 
 
 
15. Dr. Subhadeep Chatterjee 
 
Staff Scientist, 
Centre for DNA Fingerprinting & Diagnostics, (CDFD) 
Tuljaguda complex 
4-1-714 Mozamjahi Rd, Nampally 
Hyderabad – 500 001 
E-mail: subhadeep@cdfd.org.in 
 
16. Dr. Anindya Sundar Ghosh 
 
Associate Professor 
Department of Biotechnology 
Indian Institute of Technology 
Kharagpur - 721302 
Department of Biotechnology 
Tel: +91-3222-283798 
 Email: asghosh@hijli.iitkgp.ernet.in 
 
17. Dr. Mahitosh Mandal 
 
Associate Professor 
School of Medical Science and Technology 
Indian Institute of Technology 
Kharagpur - 721302 
Tel: +91-3222-283578 
 E-mail: mahitosh@smst.iitkgp.ernet.in 
 
18. Dr. Radha Rangarajan 
 
CEO, Vitas Pharma 
Technology Business Incubator 
University of Hyderabad 
C.R. Rao Road, Gachibowli 
Hyderabad 500046 
Tel: +91-9000544926 
Email: radha@vitaspharma.com 
 
 
 
19. Dr. Hemant Gautam 
 
Sr. Principal Scientist 
Institute of Genomics and Integrative Biology 
(South Campus), Sukhdev Vihar 
Mathura Road 
New Delhi-110020 
India 
Tel: Ph-011-29879326; 919868568316 
Email: hemant@igib.res.in; hemantkgautam@gmail.com 
 
20. Dr. Harpal Singh 
Professor 
Centre for Biomedical Engineering 
Block-III, Room No. 297 
Indian Institute of Technology Delhi, 
HauzKhas, New Delhi-110016 
Tel: +91-11-26591041 (office); 9810030491 (Mobile) 
Email: harpal@cbme.iitd.ac.in, harpal2000@yahoo.com 
21. Dr. Sudip K Ghosh 
 
 Professor and Head 
Department of Biotechnology 
Indian Institute of Technology Kharagpur 
Kharagpur-721302 
India 
 Tel: +91 3222 283768 
 Email: sudip@hijli.iitkgp.ernet.in 
22. Dr. Soumyava Basu 
 
Retina and Vitreous Service 
LV Prasad Eye Institute 
Patia, Bhubaneswar - 751 024 
Tel: + 91 674 3989 202 
Fax + 91 674 3987 130 
E-mail: basu@lvpei.org 
 
23. Ms. Ridhima Peravali 
 Adviser, Knowledge economy 
 British Deputy High Commission, Hyderabad 
 Hotel Taj Deccan 
Road no. 1 Banjara Hills 
 Hyderabad 500034 
 Tel: +91 40 66291950 
E-mail: Ridhima.Peravali@rcuk.ac.uk; Ridhima.Peravali@fco.gov.uk 
 
24. Dr. Nagaraju Konda 
 Postdoctoral Research Fellow,  
 University of New South Wales,  
 Sydney, Australia.  
 Tel: +91 7702506517  
 E-mail: kondavn@gmail.com 
 
25. Dr. Nagaveni Shivshetty 
 Postdoctoral Research Fellow 
 Prof. Brien Holden Eye Research Center 
 L V Prasad Eye Institute 
 L V Prasad Marg, Banjara Hills  
 Hyderabad-500034, India 
 Phone: + 91 40 30612504 
 Fax: +91 40 30612535  
 Email: vanishivshetty@lvpei.org 
 
26. Dr. Sudeep Kumar 
 Postdoctoral research fellow 
 Prof. Brien Holden Eye Research Center 
 L V Prasad Eye Institute 
 L V Prasad Marg, Banjara Hills  
 Hyderabad-500034, India 
 Phone: + 91 40 30612504 
 Email: sudeepkumar@lvpei.org  
 
 
27. Dr. Khatija Tabbasum 
 Postdoctoral research fellow 
 Prof. Brien Holden Eye Research Center 
 L V Prasad Eye Institute 
 L V Prasad Marg, Banjara Hills  
 Hyderabad-500034 India 
 Phone: +91 40 30612504 
 Fax: +91 40 30612535  
 Email: khatija@lvpei.org 
28. Ms. Pallavi Lahiri 
 
Postdoctoral Research Fellow 
Special Center for Molecular Medicine 
Jawaharlal Nehru University 
New Delhi 110067 
India 
Email: pallavilahiri@jnu.ac.in 
 
29. Mr. Sovan Banerjee 
 
Sr. Research Fellow 
Rubber Technology Centre 
Indian Institute of Technology,  
Kharagpur – 721302 
Email: sovanbanerjee1987@gmail.com 
 
30. Ms. Natalia Sharma 
 Jr. Research fellow 
 Prof. Brien Holden Eye Research Center 
 L V Prasad Eye Institute 
 L V Prasad Marg, Banjara Hills  
 Hyderabad-500034, India 
 Phone: +91 40 30612504 
     Email: natalia_jmf@yahoo.co.in 
 
 
 
31. Ms. Malabika Chakrabarti 
 
Special Center for Molecular Medicine & 
Center for Advanced Research (ICMR-CAR) 
Jawaharlal Nehru University 
New Delhi, India. 
 
32. Ms. Sanjukta Guha 
 
Project Fellow 
Prof. Brien Holden Eye Research Center 
L V Prasad Eye Institute 
Hyderabad-500034  
India 
Email: sanjukta.guha91@gmail.com 
 
33. Ms. Prerana Sharma 
 
Jr. Research Fellow 
Prof. Brien Holden Eye Research Center 
L V Prasad Eye Institute 
L V Prasad Marg, Banjara Hills  
Hyderabad-500034  
India. 
Email: preranasharma_22@yahoo.in 
 
34. Mr. Ranjit Konduri 
 
Jr. Research Fellow 
Prof. Brien Holden Eye Research Center 
L V Prasad Eye Institute 
L V Prasad Marg, Banjara Hills  
Hyderabad-500034  
India 
Email: konduriranjit@gmail.com 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Session I 
9.00 – 11 AM, 15.01.2017 
 
 
 
 
 
 
 
 
 
 
 
Antimicrobial Resistance 
 
 
Moderators 
Dipankar Ghosh, Joey Shepherd 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ex vivo cornea infection model and its utilization in evaluating detection devices 
 
Prashant Garg 
KallamAnji Reddy Campus, LV Prasad Eye Institute, BanjaraHills,Hyderabad, India. 
 
 
Infectious diseases of the eye are comon causes of occular damage and blindness in India. Early 
diagnosis and institution of appropriate therapy are key in reducing both of these nagative outcomes. 
The microbial cause varies with geographical location and a number of pathogens therefore; 
identification of the infecting microorganism plays a crucial role in successful treatment. The aim of 
the present study was to develop a reproducible model of corneal infection using ex vivo organ 
culture of corneas which can be used for drug toxicity studies and evaluating devices. 
Poly(N-isopropyl acrylamide) (PNIPAM) is a thermo-responsive polymer used in many biological 
applications and previous work has shown that antibiotic functionalized PNIPAM-HB-PNIPAM-
Van and HB-PNIPAM-Pmx  binds Gram positive and Gram negative bacteria respectively . Our 
preliminary results with series of hydrogels with functionalized polymers had capability to pick up 
bacteria from infected ex vivo corneas. The hydrogel with bound bacteria were subjected  to dye 
which showed a visible colour change indicative of the presence of pathogens. These findings 
suggest this system aids in the evaluation of microbial detection systems. 
 
 
Biodata: Dr Prashant Garg has done his specialisation in ophthalmology from RNT Medical 
College Udaipur, Rajasthan. Prior to joining LVPEI's Cornea and Anterior Segment fellowship in 
1996, he served as an Ophthalmologist in private sector hospitals. He later joined as faculty of the 
Institute in 1997 and since then has progressed steadily in his clinical and research career.              
Dr Garg has over 60 scientific publications in peer-reviewed journals to his credit and has presented 
in various forums across the world. He has been a principal investigator for several clinical trials and 
is a reviewer for ophthalmology journals, such as Cornea, Ophthalmology, Eye, Current Eye 
Research and British Journal of Ophthalmology. In 2004, he received the American Academy of 
Ophthalmology's Achievement Award. His specialisation is infectious diseases of the cornea and 
anterior segment, and eye banking procedures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Design of conformationally restricted short peptides: Antimicrobial and  
self-assembling properties 
 
Virander Singh Chauhan 
International Centre for Genetic Engineering and Biotechnology, New Delhi, India 
 
We have been working with design, synthesis and characterization of conformationally restricted 
peptides using alpha beta dehydroamino acids. Using various spectroscopic methods including CD 
and NMR, in solution, and solid state structures, we have found that presence of alpha-beta 
dehydrophenyl alanine induces beta turn in short peptides and stabilized helical structures in longer 
model peptide sequences. Using these design principles we have synthesized peptides with potential 
as antimicrobial and antifungal agents. Some of the synthesized peptides have shown significant 
antimicrobial activities. We also found that very short peptides containing 
dehydrophenylalanine self-assemble into highly stable nanostructures, entrap and release various 
biomolecules including small drugs like molecules as well as plasmids and small oligonucleotide 
sequences in slow and sustained manner. Moreover, these short peptide based nanostructures can be 
easily derivatized at their N-terminal and thus can be used for targeted delivery. 
 
 
Biodata: Prof. Chauhan obtained his Bachelors, Masters and Doctorate degree in Chemistry from 
Delhi University.  In addition to a brilliant academic record, he has also been an outstanding 
sportsman and represented Delhi University and Oxford University in athletics and cross country.  
He won the prestigious Rhodes scholarship (1974) to study at Oxford University.  Upon his return 
to India in 1979, he taught at St. Stephen’s College, IIT - Kanpur, and Delhi University.  In 1988, he 
joined the International Centre for Genetic and Biotechnology (ICGEB) and became as Director in 
1998, a position he held until 2014.His major scientific contributions are in the fields of malaria 
vaccine and drug development and in study of peptides of biological importance.  An experimental 
malaria vaccine that was developed entirely in India was taken to clinical trials also in India.  His 
current research is also focused on developing peptide based nanostructures for efficacious delivery 
of bio molecules different.  His scientific interests also include advocacy in infectious diseases like 
HIV and TB in India.  He has published more than 250 research papers and guided more than 50 
research students.   He is also deeply involved in human resource development through major 
involvement in selection process of highly prestigious Rhodes scholarships, Inlaks Scholarships and 
Felix Scholarships for Indian students.  Prof. Chauhan has received several of prestigious national 
and international awards including civil honor Padma Shri in 2012.  He is currently a member of 
UGC and Chairman of the Executive Council of National Assessment and Accreditation Council 
(NAAC).  He is also Chairman of the Pay Review Committee for the 7th Pay Commission for all 
government funded institutions of Higher Education 
 
 
 
  
Early detection pathogenic bacteria and strategies to overcome  
drug resistance using MCF7 cell line as a model 
 
Harpal Singh 
Centre for Biomedical Engineering, Indian Institute of Technology Delhi,  
All India Institute of Medical Sciences, New Delhi, India. 
 
Early detection of pathogenic bacteria is essential for pathogenic disease control, associated health 
problem and mortality. Functionalized polymeric magnetic nano-constructs (FPMNC) were 
developed as an effective immunomagnetic separator and sensing platform for selective capturing of 
Salmonella typhimurium. The developed immunoassay was specific and selective with a detection limit 
of 10 cells/ml much lower than infectious dose of salmonellosis infection. The performance of 
developed immunoassay was superior to commercially available immunomagnetic microbeads and 
conventional polystyrene plate based ELISA. 
Multidrug resistance is a resistance shown by mammalian cells or microorganisms to single or 
multiple drugs. Microorganisms employ several mechanism in attaining multidrug resistance such as 
acquired expression of efflux pumps, decreased cell wall permeability, alter target sites, increased 
mutation rate. We have developed novel biodegradable poly(lactic acid)-poly(ethylene glycol-
propylene glycol-ethylene glycol) (PLA-PEG-PPG-PEG) nanoparticles (NPs) that successfully 
overcome drug resistance in MCF7 cells over expressing Pgp receptors. PLA-PEG-PPG-PEG NPs 
were found to be spherical in shape with an average diameter of ~135nm. MCF7 cells were 
repeatedly challenged with increasing dose of free paclitaxel (PTX) to develop PTX resistant MCF7 
(PTX-R-MCF7) cells. The half maximal inhibitory concentration (IC50) of polymer loaded PTX was 
50.16nM as compared to 1784.32nM for free PTX in PTX-R-MCF7 cells. PTX loaded polymeric 
NPs also showed increase cytotoxicity and apoptosis in drug resistant breast cancer cells as 
compared to PTX based commercially available anticancer drugs Taxol and Abraxane. Paclitaxel 
loaded PLA-PEG-PPG-PEG nanoparticles had a curative effect on multidrug resistant breast cancer 
cells by increasing the amount of drug accumulation in the cytoplasm due to cellular uptake of 
polymer protected PTX through endocytosis, bypassing the P-gp receptors, and thus retaining the 
anti-proliferative effect of paclitaxel. 
 
 
Biodata: Dr. Harpal Singh is the Executive Director Stanford-India Biodesign Program, IIT-AIIMS 
Delhi. He qualified PhD from IIT Delhi and since then he is into biomedical research including 
biomedical nanotechnology. His active research focuses on the ‘Development of polymers to deliver 
drugs, particularly chemotherapeutic drugs/peptides/DNA, continuously at controlled rate for 
prolonged period of time’. He has published more than 100 research papers in National and 
International Journals of repute, presented 60 research papers in   National   and   International 
Conferences and 10 patents in the area of Polymeric Biomaterials, Nanomedicine, Drug Delivery 
Systems, Antimicrobial Polymers for Water Disinfection, Medical diagnostics & Synthesis and 
Modification of Polymers for Biomedical and Industrial Applications. 
 
  
Antibiotic Resistance and Future Strategies 
 
Hemant Gautam 
 
CSIR- Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, India. 
 
Bacterial infections are increasingly posing a serious threat to modern society as the number of 
microbial strains resistant to a number of drugs worldwide has increased in the last few years. The 
result of indiscriminate use of antibiotics, bacteria evolved resistance against many of these agents. 
In recent year, MRSA strains with a decreased susceptibility to vancomycin have been described in 
clinical isolates since late 1990s, which were named as vancomycin intermediate resistant S. aureus 
(VISA). MRSA isolates with a high-level of vancomcyin resistance (VRSA) were first recognized in 
2002 in USA. Till now few drugs are available which can be used to treat serious MRSA infections 
such as; vancomycin, daptomycin, linezolid, tigecycline, quinupristitin-dalfopristin and teicoplanin. 
Recent study on antibiotic resistance pattern of MRSA with special reference to newer antibiotics 
showed that not only the vancomycin rather resistance against linezolid and daptomycin has also 
been started to appear. In addition to MRSA, there are several outbreaks due to MRSA has also 
been reported. Our study also showed that the pathogenic strains with a resistance against all these 
new generation antibiotics have emerged needs longer dose of drug therapy. Besides these, several 
other drawbacks of these drugs such as organ toxicity, mode of drug administration, limited uses and 
increased mortality in patients cannot be neglected. There are many reasons for the drug resistance 
in developing world as well as developed world.  It has necessitated an urgent need of new agents 
that can effectively act against these strains and restrict their growth and development. To 
accomplish this requirement as well as non-availability of new generation antibiotics, researchers 
have diverted attention towards the other sources like natural sources synthetic polymers, natural 
product derivatives, Vaccine, prebiotic and probiotic, photodynamic therapy combing with new 
technologies like Bacteriophase biology, CRISPER, Nanoparticles  are a new platform for the 
creation of antimicrobial agents which have also shown some encouraging results against drug 
resistant bacterial strains. 
 
 
Biodata: Dr. Hemant Gautam is currently a senior principal investigator and professor at Institute 
of Genomics and Integrative Biology, New Delhi. His lab works on screening of natural products 
for skin diseases, evaluation of natural and synthetic molecules against antibiotic drug resistance 
bacterial strains, purification and characterization of enzymes from isolated microorganisms for 
diagnostics purpose, etc. He has over 200 publications in peer-reviewed journals of international 
repute and also authored many books and book chapters. He is a fellow member of various 
international scientific bodies and has number of prestigious awards. 
  
 
 
 
Session II 
11:30 AM – 1:00PM 15/01/2017 
 
 
 
 
 
 
 
 
 
 
Biofilm 
 
 
 
 
 
 
 
 
Moderators 
Prashant Garg, Soumyava Basu 
 
 
 
 
 
 
 
Ocular Escherichia coli : biofilm formation, antimicrobial resistance  
and gene expression 
 
Sisinthy Shivaji 
Kallam Anji Reddy Campus, LV Prasad Eye Institute, Banjara Hills, Hyderabad, India 
 
Resistant to antimicrobials is a global phenomenon and is seen in bacteria, fungi and viruses. This 
emergence is due to indiscriminate use of antibiotics coupled with the ability of the bugs to develop 
strategies to avoid the killing effect of the drugs. The ability to form a biofilm and become 
impervious to antimicrobials is a strategy encountered worldwide in a variety of pathogens. Thus 
studies focused on the molecular basis of biofilm formation would help to devise strategies to hack 
biofilm and thus overcome antimicrobial resistance. The presentation focuses on ocular E. coli with 
respect to resistance to antibiotics, biofilm forming potential and identification of genes differentially 
expressed during biofilm formation and drug resistance. The results demonstrate that ocular E. coli 
have the potential to form biofilm and cells in the biofilm are more resistant to antimicrobials. 
Further several virulent genes like those coding for pili/fimbriae, lipopolysacccharides and 
exopolysaccharides synthesis, efflux pumps etc. are up regulated. 
This is the first study on DNA microarray analysis of an ocular E. coli with a potential to form 
biofilm. 
 
 
Biodata: Prof. S Shivaji currently serves as the Director of Prof Brien Holden Eye Research Centre 
at LVPEI. He joined LVPEI, Hyderabad, in August 2013, as a Microbiology Mentor. Prior to this he 
was associated with Centre for Cellular and Molecular Biology (CCMB), Hyderabad and retired from 
there as a Director-grade Scientist in 2012 and continued as a consultant at CCMB till June 2013.His 
research interests include microbial diversity of Antarctica, Arctic, Himalayas, Stratosphere and 
other cold habitats, molecular basis of cold adaptation, molecular basis of mammalian sperm 
fertilizing ability, conservation of endangered animals and genetic basis of endometriosis. He is also 
the co-founder of the Laboratory for the Conservation of Endangered species (LaCONES) a facility 
dedicated to research on the conservation of Indian endangered animals. He is a fellow of National 
Academy of Sciences, India, Indian Academy of Sciences, India, Telangana Akademi of Sciences, 
India, and Fellow of the Association of Microbiologists of India. In recognition of his work in the 
area of Antarctic Microbiology the government of India awarded him the Antarctic Award for 
excellence in the field of Biological Sciences in 2002. He is also a recipient of Prof L S Ramaswami 
Award, Prof T C Anand Kumar Award and Prof N R Moudgal Award by Indian Society for the 
Study of Reproduction and Fertility for his contributions in area of conservation biology and 
reproductive biology in the years 2010, 2013 and 2014 respectively. He is a recipient of the first Carl 
Woese Memorial award, 2014, by the Association of Microbiologists of India. He has published 315 
research papers and 2 books and has had several international collaborations. 
  
Novel methods to treat (and grow!) biofilm 
 
Joanna Shepherd 
School of Clinical Dentistry, University of Sheffield, Sheffield, United Kingdom 
 
Bacterial biofilm is a global concern, as it can form on almost any surface and is a problem in both 
the medical field and in industry. Biofilms are less sensitive to antibiotics than planktonic bacteria, 
and the concurrent rise in antibiotic resistance means we need to seek new solutions to bacterial 
biofilm infection.  We are using low intensity ultrasound as a method of making biofilm more 
sensitive to antibiotics, and also find that low frequency ultrasound may be effective at killing 
intracellular bacteria without the use of antibiotics. We are also interested in wound dressings to 
combat bacterial biofilm in infected chronic wounds and are developing a cerium-containing 
antibacterial wound dressing amongst others. 
Our group at the University of Sheffield is also working with bacteria-binding polymers in 
collaboration with LV Prasad Eye Institute, with the ultimate aim of being able to detect microbial 
infection of the cornea and decrease the microbial burden. 
 
 
Biodata: Joey Shepherd is a non-clinical Lecturer in Microbiology at the University of Sheffield’s 
School of Clinical Dentistry.  Her research interests are largely translational in nature and primarily 
in novel approaches to detecting and treating bacterial infections without traditional use of 
antibiotics, including the use of polymer-based systems, ultrasound and acoustic vibration, novel 
wound dressings, and using 3D tissue engineered models to examine effects of infection and 
treatment on both bacteria and human cells. She currently is a co-supervisor for two PhD students 
and three postdoctoral researchers with a fourth to be appointed. At present she has collaborations 
with Sheffield Hallam University, Liverpool John Moore’s University, Bradford University, the 
LVPEI Eye Institute in Hyderabad, India. 11 Institutions across 8 European countries as part of a 
Horizon 2020 grant, and Smith & Nephew. 
  
Polymicrobial biofilms and antibiotic resistance: the case of Pseudomonas aeruginosa 
and Stenotrophomonasmaltophilia 
 
Pallavi Lahiri and Dipankar Ghosh 
Special Center for Molecular Medicine & Center for Advanced Research (ICMR-CAR), Jawaharlal Nehru University 
New Delhi, India. 
 
 
Polymicrobial infections are increasingly recognized in the aetiology of complex diseases. Unlike 
mono-microbial infections these diseases present highly complex mechanisms of pathogenesis that 
are poorly understood and frequently misdiagnosed. A typical case is presented for Pseudomonas 
aeruginosa and Stenotrophomonas maltophilia. Both are Gram’s –ve superbugs, often associated with 
nosocomial infections and reported in ocular keratitis.  Emerging data indicates this polymicrobial 
infection presents unique mechanism(s) of exacerbated antibiotic resistance and pathogenesis, which 
should be factored into treatment regimens to mitigate worse outcomes 
 
 
Biodata: Dr. Dipankar Ghosh is currently assistant professor at Special Centre for Molecular 
Medicine, Jawaharlal Nehru University, New Delhi. His research area include early host-microbe 
interactions, Quorum Signalling in gut microbiome, Probiotics, Mass Spectrometry based 
metabolomics. He did his PhD from Jadavpur University, Kolkata and postdoctoral training from 
Cleveland Clinic Foundation, USA.In 2001, Dr. Ghosh received Merlin Bumpus Best Investigator 
Award. He published number of articles in journals of international repute. He also has a patent for 
Selective Detection and Analysis of Small Molecules. 
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Non antibiotic approaches 
 
 
 
 
 
 
 
 
 
Moderators 
Stephen Rimmer, Sudip Ghosh 
  
Non-antibiotic approaches to tackling infection 
 
Sheila MacNeil 
Department of Materials Science & Engineering, University of Sheffield, United Kingdom. 
 
 
For an infection to develop in a wound there are a number of criteria to be met.  Usually there is a 
breach in the epithelial barrier layer, sufficient bacteria need to enter and survive and finally the 
immune system must be unable for whatever reason to deal with the infection. Finally formation of 
a biofilm in a wound provides an ideal environment in which cells can withstand the effects of 
antibiotics. 
 
One challenge in looking at infected wounds is that many in vitro models are too simple and most 
healthy animal models don’t mimic some of the problems that occur in man, such as chronic non-
healing ulcers in the elderly.  Working with a 3D tissue engineered skin model that is wounded and 
bacterially infected, colleagues in Sheffield have developed approaches to reduce bacteria binding 
effectively to host cells in the wound bed (using tetraspanin derived peptides) and have developed 
polymers which are intrinsically antimicrobial which do not adversely affect the skin cells.   
 
What is currently lacking from our toolkit is an immune competent model of infected skin or cornea 
in which to study the complexities of bacteria entry into wounds, bacteria biofilm formation, 
antibiotic resistance and the immune response to bacteria. There is a need to develop immune 
competent, information rich models of bacterial biofilms for future research.  
 
 
Biodata: Sheila MacNeil is Professor of Tissue Engineering in the Department of Materials Science 
and Engineering, joining the department in 2000. She has an undergraduate degree in physiology 
from the University of Aberdeen and a doctorate on the endocrinology of manic depression from 
the Medical School of the University of Sheffield. She is academic lead of the Biomaterials and 
Tissue Engineering Group within the Department. She has previously been Deputy Director of the 
Kroto Research Institute (from 2005 to 2009) and Director of the University Centre for Biomaterials 
and Tissue Engineering from 2002 to 2009, promoting interdisciplinary research between 
engineering, physical sciences and life sciences. Her current projects include developing tissue 
engineering approaches for reconstruction for burns contractures, for stimulating healing in chronic 
ulcers and she leads a group of scientists and clinicians developing a tissue engineering approach for 
repair of the weakened tissues of the female pelvic floor. She also has two Wellcome funded projects 
with India on corneal tissue engineering and early detection of infection in the cornea (with 
Professor Stephen Rimmer in Chemistry and Professor Ian Douglas in Dentistry.) 
 
 
 
 
 
 
 
 
Role of iron metabolism in bacterial virulence and antimicrobial resistance 
 
Subhadeep Chatterjee 
 
Laboratory of Plant-Microbe Interactions, Centre for DNA Fingerprinting and Diagnostics CDFD), Hyderabad, India 
 
Iron is required for virulence of several animal and plant pathogenic bacteria. The availability of iron 
within the host plays a critical role in the growth and survival of the pathogens. Ability of the 
pathogens to sequester host iron and respond to host iron status has been proposed to be critical for 
virulence and survival of plant pathogens. Although iron has been implicated in the virulence of 
pathogenic bacteria, very little is known about how pathogens acquire complex iron source and 
maintain iron homeostasis inside host. It has been proposed that pathogens modulate their 
metabolism and virulence associated functions depending on iron availability, wherein, iron 
availability act as a signal for coordinated regulation of different cellular functions. Recent work in 
our laboratory had shown that iron plays a major role in regulating diverse cellular process and 
production of virulence associated functions. We will discuss about the mechanism of iron 
dependent regulation of virulence associated function and would like to address how iron and 
virulence associated functions are co-ordinately regulated in host-pathogen interactions. 
 
 
Biodata: Subhadeep Chatterjee obtained his M. Sc degree in Biotechnology from Guru Nanak Dev 
University, Amritsar in 1998. In his post-graduation, He worked on the mechanism of stress 
response physiology of wheat (Triticumaestivum L). In 1998 he joined CCMB in Dr Ramesh V. 
Sonti’s laboratory to work on Rice-Xanthomnasoryzaepv. oryzae (Xoo) interaction. During his Ph. D 
work he identified and characterized two novel virulence functions of this economically important 
pathogen of rice 
  
Role of antimicrobial peptides in bacterial keratitis 
Sanhita Roy 
KallamAnji Reddy Campus, LV Prasad Eye Institute, Banjara Hills, Hyderabad, India. 
 
 
Microbial keratitis is the most prevalent cause of corneal infection in both developing and 
industrialized nations. In India and globally, P.aeruginosa are major causes of bacterial keratitis, 
responsible for 8-20% of all bacterial keratitis. It results in severe corneal opacity, ocular pain and 
visual impairment and predisposing factors include ocular trauma and contact lens wear. During 
infection, once the corneal integrity is breached, prompt treatment with antibiotics is required to 
stop the development of infection and its effects such as ulceration, scarring and finally loss of 
vision. The emergence of bacterial resistance to conventional antibiotics increase the necessities to 
study alternative therapeutic agents that kill the microbes and also help in modulation of the 
inflammation. This expedited the research on antimicrobial peptides and their roles in the disease. 
Corneal scrapings from Pseudomonas keratitis patients have been analyzed and differential expression 
of antimicrobial peptides belonging to different groups has been determined in these patients. We 
are also looking for agents that might induce the expression of antimicrobial peptides and combat 
bacterial infection. 
 
 
Biodata: Dr. Sanhita is currently a scientist at LV Prasad Eye Institute and her lab has been working 
on host pathogen interactions, innate immune responses in microbial keratitis and endothelial 
dystrophies. She did her PhD from CSIR-Indian Institute of Chemical Biology, Kolkata and her 
postdoc from Case Western Reserve University, Cleveland, USA. She has published extensively in 
highly reputed peer reviewed journals and also has been reviewer for prestigious journals like IOVS, 
Scientific Reports etc. Her laboratory is also funded by extramural grants obtained from various 
granting agencies, Govt. of India. 
 
  
Manufacturing and testing the efficacy of non-fouling/antimicrobial materials 
 
Maria G Katsikogianni 
 
Advanced Material Engineering, Faculty of Engineering and Informatics, University of Bradford, United Kingdom. 
 
 
Infection is an impediment to the long-term use of medical devices, representing a financial and 
healthcare burden. Towards the manufacture of small prosthetic joints with antimicrobial properties, 
1% and 10% (w/w)of triclosan impregnated polydimethysiloxane (PDMS) samples were 
compression molded on a flat or sub-micron patterned mould. The samples were assessed in terms 
of their geometric uniformity and mechanical properties using Atomic Force Microscopy (AFM).                            
Their antimicrobial efficacy was examined against Escherichia coli, Staphylococcus aureus and Staphylococcus 
epidermidis over 24 h using viable counts and Confocal Laser Scanning Microscopy coupled with 
live/dead staining. The AFM showed that increasing amounts of triclosan significantly reduced the 
Young’s modulus of the samples and reduced the quality of pattern replication. The antimicrobial 
studies showed that 1% triclosan killed all tested bacteria on both flat and patterned surfaces within 
1 h. In the case of PDMS without triclosan, patterned surfaces reduced bacterial 
adhesionandviability.Reproducible pattern replication was importantfor ensuring enhancement of 
the antimicrobial activity of triclosan-impregnated PMDS. This combined physical and chemical 
strategy provides a novel approach to generating non-fouling properties to medical device 
biomaterials. 
 
 
Biodata: Dr. Maria Katsikogianni is a Lecturer in Biomaterials Chemistry at the University of 
Bradford and an active member of the Biomaterials research community, with a degree in Chemistry 
and a PhD in Biomedical Engineering. Her research profile lies at the interface of biomaterial 
science, life sciences and engineering. She has published 19 peer reviewed papers, 3 book chapters 
and has filed 1 patent.She is particularly interested in the biomimetic design of multifunctional 
materials for relevant clinical applications, e.g. in the context of engineering and testing non-
fouling/antimicrobial materials to prevent bone infections, and in the investigation of bacteria-
material interactions. Through patterning at the sub-micron level and the incorporation of 
antimicrobial agents, a combined physical and chemical strategy is harnessed for the preparation of 
medical device surfaces that prevent microbial colonization. Enhanced pre-clinical simulation and 
therefore testing under relevant in vivo mimicking conditions informs the design and manufacturing 
of new materials.   
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Moderators 
Pradip Paik, Nikhil Kumar Singha 
 
  
Activation and inactivation of metronidazole inEntamoebaandTrichomonas 
Sudip K. Ghosh 
Department of Biotechnology, Indian Institute of Technology, Kharagpur, West Bengal, India, 
 
 
Entamoeba histolytica (Eh), and Trichomonas vaginalis (Tv), which cause diarrhea, dysentery, and vaginitis, 
respectively, are each treated with metronidazole.  We have identified oxygen-insensitive 
nitroreductase (ntr) genes in Eh, and Tv, which are homologous to those that have nonsense 
mutations in metronidazole-resistant Helicobacter pylori.  Eh and Tv also have nitroimidazole 
reductase (nim) genes, which are homologous to enzymes expressed in metronidazole-resistant 
Bacteroides fragilis.  Recombinant Entamoeba, and Trichomonas nitroreductases use NADH rather than 
NADPH of Helicobacter. Two recombinant Entamoeba nitroreductases increase the metronidazole 
sensitivity of transformed Escherichia coli.  Conversely, recombinant NIMs of Entamoeba and 
Trichmonas confer very strong metronidazole resistance to transformed bacteria. While ntr and nim 
mRNAs are variably expressed by cultured Eh and Tv, there is no simple relationship to 
metronidazole resistance in the strains tested.  We conclude that microaerophilic protists have 
bacteria-like enzymes capable of activating metronidazole  (nitroreductases) and inactivating 
metronidazole (NIMs), and these protists display some of the changes (nonsense mutations and 
gene overexpression) associated with metronidazole resistance in bacteria. An alternative pathway of 
Metronidazole activation has also been identified in Entamoeba through Malik Enzyme pathway 
 
 
Biodata: Prof. Sudip Kumar Ghosh is currently a professor and head of the department of 
Biotechnology at Indian Institute of Technology, Kharagpur. His research interests include 
Molecular and Cellular Parasitology, Nanobiotechnology, Plant Molecular Biology. He is a member 
of various scientific associations. He has more than 100 publications in Indian and International 
peer-reviewed journals. He has several projects funded by various government agencies in India. 
 
 
  
Targeting Chemo-resistant subpopulations in breast cancer: an emerging paradigm 
 
Mahitosh Mandal 
 
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India 
 
 
Chemotherapy is one of the principal modes of treatment for cancer, but the effectiveness of 
chemotherapy is limited by drug resistance which is a major challenge in cancer research. Tumour 
resistance can be either intrinsic (present before treatment), or acquired during treatment by various 
adaptive responses. At the level of the tumour, various mechanisms can regulate chemo-resistance, 
such as increased drug efflux, mutations of the drug target, DNA damage repair, activation of 
alternative signaling pathways and evasion of cell death. Moreover, chemo-resistance can also occur 
due to positive selection of a drug-resistant tumour subpopulation during assault of chemotherapy. 
One of the key interest of our group is to understand this unique adaptability of cancer cells during 
chemotherapy and design targeted therapies for these chemo-resistant clones present in tumour. 
Our current focus is to answer three big questions 1) what are the changes that occur in molecular 
level in these chemo-resistant clones which helps them survive the chemotherapy? 2) How these 
cells adapt to the changing micro-environment and influence other non-cancerous cells in the 
process? 3) What is the role of cancer stem cell in regulation of chemo-resistance in cancer? We have 
been able to identify sub-clones responsible for various drug resistance in breast cancer and are 
currently deciphering their signaling pathways. Survival pathways have always been regarded as one 
of the major regulators of chemo-resistance. We are investigating the role of MAP kinase pathways 
in chemo-resistant sub clones of breast cancer. We have also identified significant correlation 
between chemo-resistance and protective autophagy in breast cancer and unique adaptive changes in 
metabolic pathways that helps cancer cells to survive chemotherapy. Lastly, we are deciphering how 
the self-renewal pathways regulate quiescence and chemo-resistance in cancer stem cells.  
 
Biodata: Prof. Mahotosh Mandal is currently serving as an associate professor at IIT Kharagpur. 
His research group works on cancer biology, angiogenesis, apoptosis, multidrug resistance, drug 
delivery, signal transduction and biomarkers. Dr. Mandal has about 150 publications in prestigious 
journals of international repute. He is a Fellow National Academy of Science, Fellow West Bengal 
Academy of Science and Subha Mukherjee Memorial Award from Physiological Society of India 
 
  
Intraocular T-cell response in ocular TB 
 
Soumyava Basu 
Retina and Vitreous Service, LV Prasad Eye Institute, Patia, Bhubaneswar, India. 
 
Tuberculosis-associated uveitis(TBU) is a common cause of intraocular inflammation in endemic 
countries. However, absence of definitive diagnosis and unpredictable response to treatment in TBU 
leads to prolonged visual impairment in significant number of patients. Understanding the 
immunopathogenesis of TBU is critical to defining the disease as well as customizing its treatment. 
Our work has demonstrated that the intraocular T-cell response is multifunctional and specific for 
both mycobacterial and retinal autoantigens, thus revealing a unique milieu in which both microbe-
specific and autoreactive T-cells coexist. Additionally the autoreactive T-cells were resistant to 
activation-induced cell death, which suggests a mechanism for prolongation of intraocular 
inflammation. 
 
 
Biodata: Soumyava Basu heads the Retina-Vitreous and Uveitis Services at L V Prasad Eye 
Institute, Bhubaneswar. He received his medical training from the University of Mumbai, followed 
by a retina fellowship from L V Prasad Eye Institute, Hyderabad. He has worked on ‘Molecular 
diagnostics for ocular tuberculosis’ at Doheny Eye Institute, Los Angeles, USA. In 2013-14, he 
completed a yearlong sabbatical at the University of Kentucky, USA under the mentorship of Prof 
Jay Ambati. Dr Basu’s research interests lie in molecular diagnostics and immune-pathogenesis of 
ocular tuberculosis. He has received competitive research grants from Department of Science and 
Technology and Department of Biotechnology, Government of India. He has published extensively 
in peer-reviewed international journals and has been a reviewer for nearly all major ophthalmology 
journals. Dr Basu has been actively involved in framing the Indian Extra-pulmonary TB (INDEX-
TB) guidelines. He currently leads the program committee of International Working Group on 
Ocular Tuberculosis. He has also been the principal investigator for several multi-centric clinical 
trials. 
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Moderators 
Anindya Ghosh, Mahitosh Mandal 
  
Hyperbranched polymers for the disruption of quorum sensing 
 
William Martin 
School of Chemistry and Forensic Sciences, Richmond Building, University of Bradford, Bradford, United Kingdom 
 
 
Bacterial biofilms are complex mixed communities of bacteria which can form on almost any 
surface. They are a particular problem in the biomedical field as they frequently colonize medical 
devices such as indwelling catheters and prosthetics, and they are difficult to treat with conventional 
therapies as they are not sensitive to traditional treatments such as antibiotics, due to their complex 
architecture. In order to form biofilms, bacteria use Quorum Sensing (QS), which involves the use 
of molecular signals sent and received by the bacteria forming and maintaining the biofilm. Gram 
negative organisms, such as Pseudomonas aeruginosa which frequently colonizes chronic wounds and is 
also the main pathogen in the lungs of cystic fibrosis patients, use homoserine lactone (HSL) in the 
QS process. HSL is released by bacteria and binds to the LasR receptor both internally and in 
neighboring bacteria, initiating further signaling and cascades of pathogenic factors involved, for 
example, with bacterial adhesion the surface and release of virulence factors. 
Hyperbranched polymers have previously been used for the delivery of bioactive molecules in 
wound dressings, and the structure of these polymers is ideally suited to functionalization of the 
multiple end groups with. This poster will describe the synthesis of hyper-branched polymers with 
HSL homologues covalently attached to them. The ability of these materials to disrupt the QS 
process will be discussed. 
 
Biodata: Dr. William Martin is a lecturer in chemistry at School of Chemistry and Forensic Sciences, 
University of Bradford. His research areas include Natural Product Synthesis, Developing Novel 
Reactions, Mass Spectrometry, Analysis and Synthesis of Archaeologically important bio-markers. 
He has number of publications in the journals of international repute. He has over 10 years of 
teaching and research experience. 
 
  
Melimine-coated antimicrobial contact lenses 
NagarajuKonda 
KallamAnji Reddy Campus, LV Prasad Eye Institute, Banjara Hills, Hyderabad, India. 
Incidence of microbial keratitis has been reported to be 4.1 per 10,000 wearers per year when 
wearing lenses during the day and 20.9 per 10,000 wearers per year when sleeping in lenses. Several 
studies have demonstrated that use of silicone hydrogel lenses (the current lens of choice for most 
practitioners) is actually associated with a doubling of the incidence of non-infectious keratitis. 
Clearly, there remains an unmet medical need for technology to reduce the incidence of these 
adverse events. Effective control of adverse responses during contact lens wear is a goal of the 
contact lens industry, and the development of strategies to reduce significantly the number of ocular 
adverse events would be of benefit to contact lens wearers worldwide. 
Antimicrobial agents are being examined with the aim of developing antimicrobial contact lenses 
and new forms of antimicrobial lens cases. It is hoped that these developments will result in reduced 
contact lens-related microbial adverse events. Development of MK requires viable bacteria adherent 
to contact lenses, and bacterial debris adherent at the lens surface did not cause keratitis. Current 
talk will assess aspects of various antimicrobial strategies, such as cationic metals and peptides, 
selenium, quorum sensing inhibitors, and various biocidal and non-cidal agents. In addition, our 
preliminary work on Melimine-coated contact lenses to reduce the incidence of MK will be 
presented. 
 
 
Biodata: Nagaraju Konda is Research Fellow, University of New South Wales, Australia. He is a 
consultant at Srujana-Center for Innovation, L V Prasad Eye Institute, Hyderabad  
 
Non-essential PBPs and beta-lactam resistance 
Dr. Anindya S Ghosh 
Department of Biotechnology, Indian Institute of Technology, Kharagpur.India 
 
 
Penicillin-binding proteins (PBPs) catalyze the final stages of peptidoglycan biosynthesis. As the 
PBPs are the targets of beta-lactam antibiotics, here we would like to address whether the presence 
or absence of non-essential PBPs do have any effect in the beta-lactam resistance.  To address the 
issue, we have chosen a DD-carboxypeptidase of E. coli, named PBP5, encoded by dacA gene and 
plays a key role in the maintenance of cell shape. Although, PBP5 shares one of the highest copy 
numbers among the PBPs (~50% of the total PBPs), it is not essential for cell survival. To 
determine the effect of this redundant PBP on beta-lactam antibiotic susceptibility, dacA gene is 
deleted. As compared to the parent strains, both mutants become susceptible to all the beta-lactam 
antibiotics tested. Reversion to beta-lactam resistance is observed in the mutants upon 
complementing with cloned dacA, indicating the involvement of PBP5 in maintaining an intrinsic 
beta-lactam resistance and dacA homologues from different Enterobacteriaceae are able to substitute 
this behaviour of E. coli PBP5. Therefore, the involvement of PBP5 in maintaining intrinsic beta-
lactam resistance is confirmed, and we speculate that inactivation of PBP5 may be helpful to 
introduce beta-lactam susceptibility. 
In addition, for the survival of E. coli, any one of PBP1a or PBP1b is required and the deletion 
mutants with PBP1a or PBP1b deletion can survive.  To check the role of PBP 1a and 1b in beta-
lactam resistance first PBP1b (mrcB) has been deleted. The PBP1b mutants are 16–32 fold more 
sensitive to all the representative antibiotics than parent. However, the mutants regain the beta-
lactam resistance upon complementation with cloned PBP1b. In search of a specific inhibitor of 
PBP1b for neutralizing it to mimic a situation resembling PBP1b deletion, we have identified 
cefsulodin that can inhibit PBP1s without affecting the other PBPs.  Accordingly, a combination 
therapy with cefsulodin is planned with other beta-lactams. Based on the sensitivity assessment, the 
level of most effective dose of cefsulodin is determined, i.e., 1/4th of its MIC value. The 
combinations of such sub-inhibitory concentration of cefsulodin with other beta-lactam agents are 
indeed effective against the clinical isolates from various bacterial species with or without beta-
lactamase activity.  Finally, among the various combinations used, the most effective ones are with 
the cephalosporin group of beta-lactams that can reduce the resistance up to 32 fold.  Therefore, we 
can conclude that intrinsic beta-lactam resistance can be lowered by proper usage of combination 
therapy with specific PBP inhibitors. 
 
Biodata: He is currently working as associate professor at department of biotechnology, IIT 
Kharagpur. His broad research area includes bacterial cell surface macromolecules, emphasizing on 
penicillin-interactive enzymes (PIEs). Dr. Ghosh has about 32 publications in the journals of 
national and international repute. He is also a reviewer for number of peer-reviewed journals. 
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William Martin, Sanhita Roy 
  
Towards bacteria targeting particles 
 
Stephen Rimmer 
 
School of Chemistry and Forensic Sciences, Richmond Building, University of Bradford, Bradford, United Kingdom 
 
 
The presentation will outline our approach to the preparation of particles that can be loaded with 
antibiotics and which can be used for targeted local delivery to bacteria. Routes to both block 
copolymers and cross-linked particles will be shown. We will also look in advances in polymer 
characterization that are key to taking these systems to the clinic. The work will describe our use of 
DOSY NMR and size exclusion chromatography in methanol and will outline some of the 
challenges faced during this aspect of our work.  Calorimetry is used to determine the solution 
behavior of these systems and we will describe how we have used this technique to study the 
response to model peptides (Ala-Ala) that bind to vancomycin functional polymers. The study 
includes comparison of linear functional polymers to highly branched analogues and will show how 
placement of the vancomycin ligand at the chain end is required for response to bacteria. 
 
 
Biodata: Dr. Stephen Rimmer is currently a Professor at School of Chemistry and Forensic 
Sciences, University of Bradford. He is a Fellow of Royal Society of Chemistry (RSC). His broad 
research areas include Polymers, Biomaterials, Smart Polymers, Anti-microbial agents, Tissue 
Engineering, Drug delivery. His lab is focused on the synthesis and analysis of functional polymers 
and their biological applications. He has number of publications in peer-reviewed journals of 
international repute. Prof. Rimmer also has 20 years of teaching experience and spent seven years in 
industrial research. 
 
  
Novel Antibacterials: The Vitas experience 
Radha Rangarajan 
Vitas Pharma, Hyderabad, India 
 
 
Multidrug resistant infections are a major public health problem globally as morbidity and mortality 
associated with these infections are on the rise.  In order to combat drug resistance, new therapies 
are urgently needed.  However, incremental optimizations of existing classes of antibiotics are not 
the solution as existing mechanisms of resistance will eventually render them obsolete.  On the 
contrary, novel chemical scaffolds are more likely to overcome resistance and provide clear 
therapeutic benefit.  Duringthe Genomics era of the 90s, many new and essential biological 
targetswere identified and high throughput screening was employed to select chemical scaffolds 
specific to the target.  Unfortunately, these efforts did not translate into new drugs and many large 
pharmaceutical companies moved away from antibacterial research.  What then is the way forward?  
How does one identify biological targets and chemical scaffolds with a higher probability of success 
in the clinic?  The speaker will draw on her experiences as founder of Vitas Pharmaceuticals, a drug 
discovery and development company dedicated to Infectious diseases. 
 
 
Biodata: Dr. Radha Rangarajan is co-founder and CEO of Vitas Pharma, a drug discovery and 
development company, based in Hyderabad, India.  Prior to Vitas, Radha was a scientist in the Drug 
Discovery division of Dr. Reddy’s Laboratories from 2003-2009, where she led research programs in 
multiple therapeutic areas including, anti-invectives’ and metabolic disorders. Radha received her 
Bachelor’s degree in Biology from Stanford University, Master of Science degree from the University 
of Michigan, Ann Arbor and her Ph.D. in Neurobiology/Genetics from Rockefeller University, 
New York.  She was a postdoctoral fellow at the Harvard School of Public Health where she 
conducted research on the transmission of the malaria parasite. Radha was a finalist in the ET Start 
up awards- Woman Ahead category in 2016.  She was featured in Biospectrum magazine’s 10th 
anniversary issue as one of India’s top women Biotechnology entrepreneurs.  Radha is a member of 
the CII Committee on Biotechnology.  She is also member of the American Society of 
Microbiology. She has published widely, has multiple patents filed and has presented her research at 
numerous international conferences. She is on the Guest Faculty at the Indian Institute of 
Technology, Hyderabad.   
 
  
Breaching the membrane barriers for effective drug delivery 
 
Venkata Vamsi Krishna Venuganti 
Department of Pharmacy, BITS Pilani, Hyderabad Campus, Hyderabad, India 
 
 
Effective topical drug delivery is limited by the formidable barrier properties of epidermal and 
epithelial membranes. Over the years multiple techniques have been identified to overcome the 
barrier limitation and enhance the drug transport through the membranes. These broadly include 
chemical and physical methods of permeation enhancement. Some of the key factors to choose a 
suitable penetration enhancement method depends on the physico-chemical properties of drug, 
irritation potential, safety, transient nature of membrane alteration among others. Here, we present 
the breaching of skin membrane to deliver multiple therapeutics using passive and active methods. 
Utilization of nanoparticle based formulations further improves the effect of chemical or physical 
penetration enhancers. 
 
 
Biodata: Dr. Vamsi Krishna is currently working as Assistant Professor of Dept. of Pharmacy in 
BITS, Hyderabad. He pursued his Ph. D. (Pharmaceutical Sciences) at South Dakota State 
University, USA, 2010.  His research interests include Nano/micro-carrier mediated Drug Delivery 
for Transdermal/Topical applications, Non-Viral Carriers for Gene-based Drug Delivery and 
Development of Biomaterials for Drug Delivery. He has authored many research articles including 
book chapter. He is reviewer for International Journals of Journal of Biomedical Nanotechnology, 
Material Science and Engineering C, Drug Development and Industrial Pharmacy, etc. He is the 
recipient of several grants from DBT, DST, UKICAT-MA by DBT-MRC etc. 
 
 
 
  
New class of polymeric nano-hybrid material based on POSS and its biomedical 
applications 
 
Nikhil Kumar Singha 
Rubber Technology Centre, Indian Institute of Technology, Kharagpur, India 
 
 
POSS is new classes of 3-dimentional nano-material which consists of alternating Si-O bonds to 
form a cage like structure where Si atoms are exist as vertices. Depending on the types of 
functionality present in the vertex positions various types of mono and multifunctional smart 
materials can be prepared. Here we describethe syntheses of some new class of compounds based 
on POSS and their potential use in the field of biomedical application especially as a delivery system 
for drug due to its non-toxicity, biocompatibility, chemical inertness, biodegradability and 
antithrombogenic properties etc. Methacryloyl-POSS (MA-POSS) was used to polymerize over the 
surface of grapheme oxide (GO) via surface initiated atom transfer radical polymerization (SI-
ATRP) to prepare polymer brush over GO. The hybrid material (GO-PMAPOSS) was synthesized 
via SI-ATRP of methacryloyl-POSS (MAPOSS) on GO surface and was duly characterized by FTIR, 
GPC, TEM, FESEM, goniometry and TGA analyses. Later, we introduced this GO-PMAPOSS 
hybrid material into starch-polyacrylamide based semi IPN hydrogel which was prepared by using 
free radical polymerization of acrylamide in presence of starch. TEM and FESEM analyses revealed 
that GO-PMAPOSS hybrid material formed a network like structure inside the hydrogel through 
self-association of the hydrophobic POSS chains which helped to reduce the platelet adhesion as 
compared to hydrogel without GO-PMAPOSS hybrid material. The composite hydrogel also 
showed superior red blood cell compatibility and good cytocompatibility. Moreover, the composite 
hydrogel was capable of performing controlled release of drug. Functionalize POSS can also be used 
as an initiator for ring opening polymerization (ROP) reaction. Hydroxyl terminated POSS was used 
as an initiator to perform a strategic ROP of ε -caprolactone and α -propargyl-ε -caprolactone. After 
that azide terminated poly(tert-butyl acrylate) (PtBA) was grafted onto functional PCL via Cu-
catalyzed azide-alkyne ‘click’ (CuAAC) reaction and later on it was hydrolyzed to get an amphiphilic-
POSS tethered PCL-graft-PAA polymer. The as prepared polymer was characterized by GPC, NMR, 
FT-IR analyses and the self-assembly behavior of the amphiphilic graft co-polymer in water at 
various concentration was analyzed by FESEM and HRTEM analysis. It was observed that 
depending on the concentration of the graft co-polymer in water it changes its morphology from 
micelles to worm-like to core-shell structure. Change of the size of the micelle with pH of the 
solution was measured using DLS analysis and after that the micelle was employed to deliver 
Rhodamine B, as a model compound.  
 
Biodata: He is currently a Professor at IIT Kharagpur. His current research areas are Tailor-made 
polymers, Block (AB & ABA) & graft copolymers, Smart self-healing and self-cleaning polymers etc. 
He has been honored with Prof. M. Santappa award by Society of Polymer Science, India (2014) and 
Fulbright Senior Fellowship by USIEF, 2013-2014. He has four patents His research is being funded 
by DST, DBT, CSIR and many companies like Bridgestone Corporation, Tokyo, Japan, etc.  
“NO” delivery through crossed-linked polymer capsules 
 
Pradip Paik 
School of Engineering Sciences and Technology, University of Hyderabad, Hyderabad, Telangana, India 
 
 
In the cellular system during chemical reaction, the NO-free radical is an important cellular signaling 
molecule which has an extensive role in variety biological processes. Appropriate regulation of NO 
is essential for maintaining the overall health of the body and deficiency, or overproduction is 
known to be associated with some pathology. NO roles in different physiological events like 
vasodilation and hypertension in preeclampsia, mucus production, infection and wound care 
management sleep control and regulation, its role in antimicrobial applications and cancer treatment, 
and most importantly in proper functioning of the immune system were well documented. A new 
type of cross-linked polymer nanocapsule has been designed and its efficient delivery to the targeted 
site will be presented in this talk.  
 
 
Biodata: Dr. Pradip Paik is currently assistant professor of the School of Engineering Sciences and 
Technology, University of Hyderabad, India with a 10 member research group. After spending a 
couple of years in Israel and NUS Singapore Dr. Paik come back to India on 2010. His research area 
focused on the new bio-materials and nano-capsules design and synthesis for drug and gene delivery 
and for therapeutic applications. He is co-author of 4 patent (provisional), 80 research articles 
including proceedings, and a couple of book and book chapters. 2 Ph.D. and 7 M.Tech Scholars 
have already been completed their dissertation under his supervision. Dr. Paik is recipient of the 
awards:  ISCA 'Young Scientist Award’-2007, SwarnayaJayanty Endowment Fellowship (IIM-2011), 
Visiting Scientist/Faculty,-Israel 2012 and 2015; Research paper cash awards etc. Many of his 
scholars awarded for best dissertation and best oral presentation awards. Paik’s research group 
(Advanced Polymers and Biomaterials) is funded by DBT, DST, UGC, BHEL etc.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Workshop discussion: 
 
 
Like workshops in past, we decided to spend 2 half days on collaborative discussion. To begin the 
discussion and identify areas of interest among participants they were asked to think and write three 
areas that they would wish to work if they have funding available to them. The themes that emerged 
from this discussion were:  
 Early detection of pathogenic organisms and drug resistance;  
 Biofilm;  
 Antimicrobial peptides;  
 Targeted drug delivery  
 
Participants were asked to choose groups that match the area their interest and than discuss 
brainstorm what is the problem and how can we solve it. Subsequent day started with having 
discussion on low hanging projects and how each project can be executed.  
Summary of discussion: 
Some of the projects that were considered having potential for collaboration were: 
 Tackling beta lactum resistance using combination therapy with cefsulodin. The laboratory of 
Dr. Anindya S Ghosh (Department of Biotechnology, Indian Institute of Technology, 
Kharagpur.India)identified that cefsulodin inhibits PBP1s without affecting the other PBPs a 
combination therapy ofsub-inhibitory concentration of cefsulodinwith other beta-lactam agents was 
found to effective against the clinical isolates from various bacterial species with or without beta-
lactamase activity.  Dr Prashant Garg (L V Prasad Eye Institute expressed interest in testing this 
combination against beta lectum resistant ocular isolates. 
 
 Overcome multidrug resistance: Another approach considered to overcome multidrug 
resistance was biodegradable poly (lactic acid)-poly(ethylene glycol-propylene glycol-ethylene 
glycol) (PLA-PEG-PPG-PEG) nanoparticles (NPs) that Prof Harpal Singh (Centre for 
Biomedical Engineering, Indian Institute of Technology Delhi) has shown to successfully 
overcome drug resistance in MCF7 cells overexpressing Pgp receptors.  
 Targeted drug therapy using HBPNIPAM: Prof Rimmer in collaboration with 
DrVenuganti and Dr Garg is working on using hyper branched PNIPAM polymers for 
targeted drug delivery.  
 Antimicrobial Peptides as alternative to antibiotics: Dr V S Chauhan’s laboratory (International 
Centre for Genetic Engineering and Biotechnology, New Delhi) has synthesized peptides with 
potential as antimicrobial and antifungal agents. The group decided to assess highly branched 
PNIPAM polymers modified with AMPs and assess their stability and functions. It was decided that 
group would screen small molecule modulators, molecules from bacteriophages or biosensors that 
inhibit bacterial cellular metabolism. DrSanhita’s laboratory has studied differential expression of 
antimicrobial peptides belonging to different groups in Pseudomonas keratitis patients and felt that 
looking for agents that might induce the expression of antimicrobial peptides or supplementing from 
outside for combating bacterial and fungal infections will be worthwhile. 
 Biofilm: The group realized that organisms within biofilm exhibit much higher levels of drug 
resistance and exploring the biofilm inhibition using natural or chemical inhibitors or biofilm hackers 
as an approach for tackling drug resistance will be a good approach for tackling antimicrobial 
resistance. Dr. SubhadeepChatterjeein a recent work had shown that iron plays a major role in 
regulating diverse cellular process and production of virulence associated functions including biofilm. 
Dr. Joanna Shepherd (School of Clinical Dentistry, University of Sheffield, Sheffield, United 
Kingdom) is working on the use of ultrasound for the disruption of biofilm. Dr William Martin has 
synthesized hyper-branched polymers with homoserine lactone (HSL) homologues covalently 
attached to them, which have the ability to disrupt the QS process necessary for biofilm formation.  
 There was a lot of interest tackling problem of drug resistant tuberculosis. Following 
activities were decided by the group:  
- To test Vancomycin functionalized polymer for inhibition of M.tuberculosis in culture 
- Work toward animal model – Zebra fish and mice 
- To test different molecules (drugs) that have potential of being effective against drug 
resistant pathogens 
- Plan in-vitro experiments 
- Meet in Delhi to write grant proposal 
 Rapid detection of infection including drug resistance: There was interest among the 
group on exploring different approaches for rapid detection of nature of infection and drug 
resistance using systems based on bacterial binding polymers, antibodies or aptamers or 
genome analysis and identifying drug resistance hacking resistance determinants and 
developing a simple colorimetric or florescent test. 
 Management of parasitic infections: A section of participants were interested in evaluating surface 
markers of ameobae for developing a simple to use diagnostic test as well as therapy 
 
 
